Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full
report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT02548585”
into the search box and click “Search”.
• www.clinicaltrialsregister.eu. Once you are on the website, click
“Home & Search”, then type “2014-003716-36” in the search box and
click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D5670C00002” into the search box, and click “Find a Study”.
Official study title: A Phase1/2, Randomized, Blinded, Placebo-controlled,
Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and
Pharmacokinetics of MEDI0382 in Overweight and Obese Subjects with a History
of Type 2 Diabetes Mellitus
Protocol number: D5670C00002
MedImmune, Ltd, a member of the AstraZeneca Group of companies and has its
headquarters at Milstein Building, Granta Park, Cambridge CB21 6GH.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for participants.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization
focused on educating and informing the public about clinical research participation. CISCRP is not involved
in recruiting patients for clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 510 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
8
Version: V1.2 09/2018